You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 17, 2025

Drugs in ATC Class R01B


✉ Email this page to a colleague

« Back to Dashboard


Subclasses in ATC: R01B - NASAL DECONGESTANTS FOR SYSTEMIC USE

R01B Market Analysis and Financial Projection

The ATC Class R01B (nasal decongestants for systemic use) encompasses medications like phenylephrine and pseudoephedrine, often combined with antihistamines for treating allergic rhinitis and cold-related congestion. Market dynamics and patent activity reflect evolving consumer needs, regulatory shifts, and innovations aimed at improving efficacy and safety.

Market Dynamics

  1. Growth Drivers

    • The global nasal sprays market, including systemic decongestants, grew to $9.2 billion in 2021 and is projected to reach $16.9 billion by 2031 (6.2% CAGR)[2]. Systemic decongestants dominate due to their role as first-line OTC solutions for congestion[6][8].
    • Rising respiratory diseases (allergic rhinitis, chronic sinusitis) and air pollution amplify demand. The segment for multi-dose decongestant sprays is expanding, driven by controlled usage awareness to avoid rebound congestion[6][8].
  2. Regional Trends

    • North America leads market share (40% in 2021), supported by robust pharmaceutical R&D and OTC availability[2][8].
    • Asia-Pacific shows rapid growth (~7% CAGR)[2], fueled by increasing healthcare access and allergy prevalence.
  3. Key Players
    Major companies include Bayer, GlaxoSmithKline, Cipla, and Abbott Laboratories[6]. Strategic R&D focuses on preservative-free formulations and pediatric safety[6][16].


Patent Landscape

Recent patents highlight innovations to mitigate side effects and enhance delivery: Patent Focus Key Developments Example
Combination Therapies Integrating decongestants with moisturizers (e.g., dexpanthenol) to reduce mucosal dryness. US20200246311A1 combines xylometazoline with hyaluronic acid for improved tolerability[4][16].
Extended-Release Formulations Sustained-action tablets/pills for prolonged relief. US8092831B2 patents a 12–24-hour antihistamine-decongestant system with layered coatings[5].
Drug Delivery Optimization Portable spray devices and pH-balanced solutions for better absorption. Near-infrared spectroscopy patents (e.g., by Purdue Pharma) enable precise quality control[3][15].

Challenges and Opportunities

  • Regulatory Scrutiny: Debates over phenylephrine efficacy may push reformulation efforts[6][16].
  • Competition: Over 800 U.S. patents in adjacent areas (e.g., nasal antihistamines) signal crowded innovation[3][15].
  • Emerging Applications: Non-respiratory uses (e.g., migraine relief) and AI-driven drug discovery could open new markets[8][17].

The R01B market remains robust, with patents increasingly targeting patient-centric formulations to balance efficacy and safety.

References

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC4564658/
  2. https://www.alliedmarketresearch.com/nasal-spray-market-A14430
  3. https://www.globenewswire.com/news-release/2025/03/14/3043095/0/en/Comprehensive-Near-Infrared-Spectroscopy-Patent-Landscape-Report-Reveals-Market-to-Reach-USD-989-8-Million-by-2032.html
  4. https://patents.google.com/patent/US20200246311A1/en
  5. https://patents.google.com/patent/US8092831B2/en
  6. https://www.biospace.com/nasal-decongestant-market-competitive-analysis-and-key-developments
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC4208566/
  8. https://www.globenewswire.com/news-release/2025/03/03/3035394/0/en/Global-Nasal-Sprays-Market-Poised-for-Significant-Growth-Expected-to-Reach-USD-28-345-5-Million-by-2035-grow-at-a-CAGR-of-6-0-Future-Market-Insights-Inc.html
  9. https://www.energy.gov/sites/prod/files/2020/10/f79/hfto-2019-patent-analysis.pdf
  10. https://www.atxadvisors.com/accountable-update/2025/1/9/q4-2024-market-review-an-analysis-of-market-dynamics
  11. https://atcddd.fhi.no/atc_ddd_index/?code=R01&showdescription=yes
  12. https://atcddd.fhi.no/atc_ddd_index/?code=R01BA53
  13. https://www.energy.gov/sites/default/files/2023-03/hfto-2021-patent-analysis.pdf
  14. https://www.futuremarketinsights.com/reports/nasal-spray-market
  15. https://ip.com/blog/2025-patent-trends-challenges-and-innovations-shaping-the-future-of-technology/
  16. https://patents.justia.com/patent/20200246311
  17. https://www.imarcgroup.com/patent-analytics-market

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.